Natural History of Open-Angle Glaucoma

Ophthalmology

Volumn 116, Issue 12, 2009, Pages 2271-2276

  Heijl, Anders ^a   Bengtsson, Boel ^a   Hyman, Leslie ^b   Leske, M Cristina ^b  

^a LUND UNIVERSITY   (Sweden)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH TENSION GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL TENSION GLAUCOMA; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; PSEUDOEXFOLIATION GLAUCOMA; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; EXFOLIATION SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PERIMETRY; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELDS;

EID: 70549112634     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.06.042     Document Type: Article

References (38)

1. Collaborative Normal-Tension Glaucoma Study Group. Natural history of normal-tension glaucoma. Ophthalmology 108 (2001) 247-253
2. Leske M.C., Heijl A., Hyman L., Bengtsson B., and Early Manifest Glaucoma Trial Group. Early Manifest Glaucoma Trial design and baseline data. Ophthalmology 106 (1999) 2144-2153
3. American Academy of Ophthalmology: Preferred Practice Pattern. Primary Open-Angle Glaucoma (2005), American Academy of Ophthalmology, San Francisco 3
4. Ritch R. Exfoliation syndrome. Curr Opin Ophthalmol 12 (2001) 124-130
5. Heijl A., Leske M.C., Bengtsson B., et al., Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120 (2002) 1268-1279
6. Kass M.A., Heuer D.K., Higginbotham E.J., et al., Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713 discussion 829-30
7. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
8. Bengtsson B., Lindgren A., Heijl A., et al. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand 75 (1997) 184-188
9. Heijl A., Lindgren G., and Olsson J. A package for the statistical analysis of visual fields. Doc Ophtahlmol, Proc Ser 49 (1987) 153-168
10. Heijl A., and Patella V.M. Essential Perimetry the Field Analyzer Primer. 3rd Ed. (2002), Carl Zeiss Meditec, Dublin, CA 55
11. Hodapp E., Parrish II R.K., and Anderson D.R. Clinical Decisions in Glaucoma (1993), Mosby, St. Louis 52-61
12. Mills R.P., Budenz D.L., Lee P.P., et al. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 141 (2006) 24-30
13. Heijl A., Leske M.C., Bengtsson B., et al., Early Manifest Glaucoma Trial Group. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand 81 (2003) 286-293
14. Heijl A., Bengtsson B., Chauhan B.C., et al. A comparison of visual field progression criteria of 3 major glaucoma trials in Early Manifest Glaucoma Trial patients. Ophthalmology 115 (2008) 1557-1565
15. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 (2004) 1627-1635
16. Leske M.C., Heijl A., Hussein M., et al., Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 121 (2003) 48-56
17. Leske M.C., Heijl A., Hyman L., et al., Early Manifest Glaucoma Trial Group. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114 (2007) 1965-1972
18. European Glaucoma Prevention Study (EGPS) Group. Results of the European Glaucoma Prevention Study. Ophthalmology 112 (2005) 366-375
19. Gordon M.O., Beiser J.A., Brandt J.D., et al., The Ocular Hypertension Treatment Study Group. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 714-720 discussion 829-30
20. European Glaucoma Prevention Study (EGPS) Group. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. Ophthalmology 114 (2007) 3-9
21. Iwase A., Suzuki Y., Araie M., et al., Tajimi Study Group Japanese Glaucoma Society. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 111 (2004) 1641-1648
22. Werner E.B., Adelson A., and Krupin T. Effect of patient experience on the results of automated perimetry in clinically stable glaucoma patients. Ophthalmology 95 (1988) 764-767
23. Wood J.M., Wild J.M., Hussey M.K., and Crews S.J. Serial examination of the normal visual field using Octopus automated projection perimetry, evidence for a learning effect. Acta Ophthalmol (Copenh) 65 (1987) 326-333
24. Heijl A., and Bengtsson B. The effect of perimetric experience in patients with glaucoma. Arch Ophthalmol 114 (1996) 19-22
25. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. Am J Ophthalmol 134 (2002) 499-512
26. Hattenhauer M.G., Johnson D.H., Ing H.H., et al. The probability of blindness from open-angle glaucoma. Ophthalmology 105 (1998) 2099-2104
27. Kwon Y.H., Kim C.S., Zimmerman M.B., et al. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol 132 (2001) 47-56
28. Wilson M.R., Kosoko O., Cowan Jr. C.L., et al. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies. Am J Ophthalmol 134 (2002) 399-405
29. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 15 (1994) 299-325
30. Broman A.T., Quigley H.A., West S.K., et al. Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci 49 (2008) 66-76
31. Hollows F.C., and Graham P.A. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 50 (1966) 570-586
32. Leske M.C. Open-angle glaucoma-an epidemiologic overview. Ophthalmic Epidemiol 14 (2007) 166-172
33. Sommer A., Tielsch J.M., Katz J., et al., Baltimore Eye Survey Research Group. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans, the Baltimore Eye Survey. Arch Ophthalmol 109 (1991) 1090-1095
34. Coffey M., Reidy A., Wormald R., et al. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 77 (1993) 17-21
35. Dielemans I., Vingerling J.R., Wolfs R.C., et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands, the Rotterdam Study. Ophthalmology 101 (1994) 1851-1855
36. Mitchell P., Smith W., Attebo K., and Healey P.R. Prevalence of open-angle glaucoma in Australia, the Blue Mountains Eye Study. Ophthalmology 103 (1996) 1661-1669
37. Bonomi L., Marchini G., Marraffa M., et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population, the Egna-Neumarkt Study. Ophthalmology 105 (1998) 209-215
38. Weih L.M., Nanjan M., McCarty C.A., and Taylor H.R. Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108 (2001) 1966-1972